In August 2015,. ,. (BCS) solubility and permeability. On the basis of this classification,, or w
2.S.2.2 – 3.2.S.2.6.(Q8), Quality Risk Management (Q9) and Pharmaceutical Quality Systems (Q10).
The European Commission DG Health & Consumers has published the new EU-GMP Chapter 8 on Complaints,